ARIAD PHARMACEUTICALS INC Proceeds from Common Stock Issued
ARIAD PHARMACEUTICALS INC reported Proceeds from Common Stock Issued of $310.04 million for the 12-month period ending 2013-12-31, per its 10-K filed 2016-02-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2016-02-29
- ARIAD PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2013-12-31 was $0.00.
- ARIAD PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2013-09-30 was $0.00.
- ARIAD PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2013-06-30 was $0.00.
- ARIAD PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2013-03-31 was $310.04M.
- ARIAD PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2013 was $310.04M.
- ARIAD PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2011 was $243.06M, a 322.60% increase from fiscal 2010.
- ARIAD PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2010 was $57.52M, a 1.46% decline from fiscal 2009.
- ARIAD PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2009 was $58.37M.
| Period end | Proceeds from Issuance of Common Stock 0 month | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $310.04M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $310.04M 10-Q · filed 2014-11-07 | ||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $310.04M 10-Q · filed 2014-08-08 | |||||
| 2013-03-31 | $310.04M 10-Q · filed 2014-05-09 | ||||||
| 2013-01-29 | $310.00M 10-Q · filed 2014-05-09 | $310.00M 10-K · filed 2016-02-29 | $310.00M 10-Q · filed 2013-11-12 | ||||
| 2011-12-31 | $234.98M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $235.48M derived: sum of 2 quarters · filed 2014-03-03 | $243.06M 10-K · filed 2014-03-03 | ||||
| 2011-12-20 | $243.10M 10-K · filed 2014-03-03 | ||||||
| 2011-09-30 | $499.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $8.08M 10-Q · filed 2011-11-07 | |||||
| 2011-06-30 | $7.58M 10-Q · filed 2011-08-09 | ||||||
| 2010-12-31 | $54.89M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $54.89M derived: sum of 2 quarters · filed 2013-03-01 | $57.52M 10-K · filed 2013-03-01 | ||||
| 2010-10-29 | $57.50M 10-K · filed 2013-03-01 | ||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $2.62M 10-Q · filed 2011-11-07 | |||||
| 2010-06-30 | $2.62M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $58.37M 10-K/A · filed 2012-03-30 | ||||||
| 2009-02-25 | $22.80M 10-K · filed 2015-03-02 | $22.80M 10-K · filed 2014-03-03 |